Protective role of Toll-like Receptor 3-induced type I interferon in murine coronavirus infection of macrophages

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304 · see citing works

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · see citing works

Coronaviruses post-SARS: update on replication and pathogenesis

Perlman, S. M., & Netland, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2147 · Cited by 1,766 · see citing works

IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors

Honda, K., & Taniguchi, T. (2006) · Nature reviews. Immunology · doi:10.1038/nri1900 · Cited by 1,676 · see citing works

TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β

Kagan, J. C., Su, T., Horng, T., Chow, A. Y., Akira, S., & Medzhitov, R. M. (2008) · Nature Immunology · doi:10.1038/ni1569 · Cited by 1,256 · see citing works

Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus

Weiss, S. R., & Navas-Martin, S. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.635-664.2005 · Cited by 1,256 · see citing works

Lung pathology of fatal severe acute respiratory syndrome

Nicholls, J. M., Poon, L. L., Lee, K. C., Ng, W. F., Lai, S. T., Leung, C. Y., Chu, C. M., Hui, P. K., Mak, K. L., Lim, W., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13413-7 · Cited by 1,076 · see citing works

Interferon regulatory factors: the next generation

Mamane, Y., Heylbroeck, C., Génin, P., Algarté-Génin, M., Servant, M. J., Page, C. L., DeLuca, C., Kwon, H., Lin, R., & Hiscott, J. B. (1999) · Gene · doi:10.1016/s0378-1119(99)00262-0 · Cited by 570 · see citing works

Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands

Barbalat, R., Lau, L., Locksley, R. M., & Barton, G. M. (2009) · Nature Immunology · doi:10.1038/ni.1792 · Cited by 453 · see citing works

Toll-Like Receptor Signaling Inhibits Hepatitis B Virus Replication In Vivo

Isogawa, M., Robek, M. D., Furuichi, Y., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.7269-7272.2005 · Cited by 443 · see citing works

Coronavirus infection of the central nervous system: host–virus stand-off

Bergmann, C. C., Lane, T. E., & Stohlman, S. A. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1343 · Cited by 398 · see citing works

Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon

Cervantes‐Barragán, L., Züst, R., Weber, F., Spiegel, M., Lang, K. S., Akira, S., Thiel, V., & Ludewig, B. (2006) · Blood · doi:10.1182/blood-2006-05-023770 · Cited by 397 · see citing works

Deubiquitinating and Interferon Antagonism Activities of Coronavirus Papain-Like Proteases

Clementz, M. A., Chen, Z., Banach, B. S., Wang, Y., Sun, L., Ratia, K. M., Báez-Santos, Y. M., Wang, J., Takayama, J., Ghosh, A. K., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02406-09 · Cited by 306 · see citing works

Regulation of interferon and Toll‐like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms

Hu, X., Chakravarty, S. D., & Ivashkiv, L. B. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00707.x · Cited by 303 · see citing works

Tumor Necrosis Factor Alpha Exerts Powerful Anti-Influenza Virus Effects in Lung Epithelial Cells

Seo, S. H., & Webster, R. G. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1071-1076.2002 · Cited by 275 · see citing works

SARS coronavirus and innate immunity

Frieman, M. B., Heise, M. T., & Baric, R. S. (2007) · Virus Research · doi:10.1016/j.virusres.2007.03.015 · Cited by 236 · see citing works

Murine Coronavirus Mouse Hepatitis Virus Is Recognized by MDA5 and Induces Type I Interferon in Brain Macrophages/Microglia

Roth-Cross, J. K., Bender, S. J., & Weiss, S. R. (2008) · Journal of Virology · doi:10.1128/jvi.01199-08 · Cited by 228 · see citing works

Activation of anti-hepatitis C virus responses via Toll-like receptor 7

Lee, J., Wu, C. C. N., Lee, K. J., Chuang, T., Katakura, K., Liu, Y., Chan, M. D., Tawatao, R. I., Chung, M. T. M., Shen, C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510801103 · Cited by 212 · see citing works

Evaluation of Immunomodulators, Interferons and Known in Vitro SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice

Barnard, D. L., Day, C. W., Bailey, K. W., Heiner, M., Montgomery, R. A., Lauridsen, L., Chan, P. K. S., & Sidwell, R. W. (2006) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020601700505 · Cited by 210 · see citing works

Murine Toll-Like Receptor 2 Activation Induces Type I Interferon Responses from Endolysosomal Compartments

Dietrich, N. L., Lienenklaus, S., Weiß, S., & Gekara, N. O. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010250 · Cited by 148 · see citing works

Induction of type I interferon by RNA viruses: cellular receptors and their substrates

Baum, A., & García‐Sastre, A. (2009) · Amino Acids · doi:10.1007/s00726-009-0374-0 · Cited by 141 · see citing works

A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo

Day, C. W., Baric, R. S., Cai, S. X., Frieman, M. B., Kumaki, Y., Morrey, J. D., Smee, D. F., & Barnard, D. L. (2009) · Virology · doi:10.1016/j.virol.2009.09.023 · Cited by 139 · see citing works

Toll-like receptors: key players in antiviral immunity

Arpaia, N., & Barton, G. M. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.006 · Cited by 138 · see citing works

PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production

Zheng, D., Chen, G., Guo, B., Cheng, G., & Tang, H. (2008) · Cell Research · doi:10.1038/cr.2008.294 · Cited by 135 · see citing works

Activation of toll-like receptor signaling pathway for protection against influenza virus infection

Wong, J. P., Christopher, M. E., Viswanathan, S., Karpoff, N. E. C., Dai, X., Das, D., Sun, L., Wang, M., & Salazar, A. Μ. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.048 · Cited by 135 · see citing works

Nonstructural Protein 2 of Porcine Reproductive and Respiratory Syndrome Virus Inhibits the Antiviral Function of Interferon-Stimulated Gene 15

Sun, Z., Lǐ, Y., Ransburgh, R., Snijder, E. J., & Fāng, Y. (2012) · Journal of Virology · doi:10.1128/jvi.06466-11 · Cited by 132 · see citing works

Type I IFN-Mediated Protection of Macrophages and Dendritic Cells Secures Control of Murine Coronavirus Infection

Cervantes‐Barragán, L., Kalinke, U., Züst, R., König, M. F., Reizis, B., López-Macías, C. I. R., Thiel, V., & Ludewig, B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.2.1099 · Cited by 124 · see citing works

TLR7/8 Triggering Exerts Opposing Effects in Acute versus Latent HIV Infection

Schlaepfer, E., Audigé, A., Joller, H., & Speck, R. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.2888 · Cited by 119 · see citing works

Murine Coronavirus Replication-Induced p38 Mitogen-Activated Protein Kinase Activation Promotes Interleukin-6 Production and Virus Replication in Cultured Cells

Banerjee, S. R., Narayanan, K., Mizutani, T., & Makino, S. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.5937-5948.2002 · Cited by 118 · see citing works

TLR3 Is Essential for the Induction of Protective Immunity against Punta Toro Virus Infection by the Double-Stranded RNA (dsRNA), Poly(I:C12U), but not Poly(I:C): Differential Recognition of Synthetic dsRNA Molecules

Gowen, B. B., Wong, M., Jung, K., Sanders, A. B., Mitchell, W. M., Alexopoulou, L., Flavell, R. A., & Sidwell, R. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5200 · Cited by 116 · see citing works

Pathogenesis of Murine Coronavirus in the Central Nervous System

Bender, S. J., & Weiss, S. R. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9202-2 · Cited by 116 · see citing works

Mouse Hepatitis Virus Does Not Induce Beta Interferon Synthesis and Does Not Inhibit Its Induction by Double-Stranded RNA

Zhou, H., & Perlman, S. M. (2006) · Journal of Virology · doi:10.1128/jvi.01512-06 · Cited by 112 · see citing works

A critical function of toll‐like receptor‐3 in the induction of anti‐human immunodeficiency virus activities in macrophages

Zhou, Y., Wang, X., Liu, M., Hu, Q., Song, L., Ye, L., Zhou, D., & Ho, W. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03270.x · Cited by 110 · see citing works

Enhanced green fluorescent protein expression may be used to monitor murine coronavirus spread in vitro and in the mouse central nervous system

Sarma, J. D., Scheen, E., Seo, S.-H., Koval, M. H., & Weiss, S. R. (2002) · Journal of NeuroVirology · doi:10.1080/13550280260422686 · Cited by 109 · see citing works

Mouse Hepatitis Coronavirus A59 Nucleocapsid Protein Is a Type I Interferon Antagonist

Ye, Y., Hauns, K., Langland, J., Jacobs, B. L., & Hogue, B. G. (2006) · Journal of Virology · doi:10.1128/jvi.01634-06 · Cited by 108 · see citing works

Type I Interferons Are Essential in Controlling Neurotropic Coronavirus Infection Irrespective of Functional CD8 T Cells

Ireland, D. D. C., Stohlman, S. A., Hinton, D. R., Atkinson, R., & Bergmann, C. C. (2007) · Journal of Virology · doi:10.1128/jvi.01794-07 · Cited by 104 · see citing works

The Pathogenesis of Murine Coronavirus Infection of the Central Nervous System

Hosking, M., & Lane, T. E. (2010) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v30.i2.20 · Cited by 93 · see citing works

Activation of Toll-Like Receptor 3 Impairs the Dengue Virus Serotype 2 Replication through Induction of IFN-β in Cultured Hepatoma Cells

Liang, Z., Wu, S., Li, Y., Li, H., Wu, M., Jiang, L., Feng, L., Zhang, P., & Huang, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023346 · Cited by 91 · see citing works

Decreased Dengue Replication and an Increased Anti-viral Humoral Response with the use of Combined Toll-Like Receptor 3 and 7/8 Agonists in Macaques

Sariol, C. A., Martínez, M. I., Rivera, F., Rodríguez, I. V., Pantoja, P., Abel, K., Arana, T., Giavedoni, L. D., Hodara, V. L., White, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019323 · Cited by 74 · see citing works

PLP2 of Mouse Hepatitis Virus A59 (MHV-A59) Targets TBK1 to Negatively Regulate Cellular Type I Interferon Signaling Pathway

Wang, G., Chen, G., Zheng, D., Cheng, G., & Tang, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017192 · Cited by 70 · see citing works

Effect of Pretreatment with Toll‐like Receptor Agonists in a Mouse Model of Herpes Simplex Virus Type 1 Encephalitis

Boivin, N., Sergerie, Y., Rivest, S., & Boivin, G. (2008) · The Journal of Infectious Diseases · doi:10.1086/590671 · Cited by 65 · see citing works

PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants

Ichinohe, T., Ainai, A., Tashiro, M., Sata, T., & Hasegawa, H. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.074 · Cited by 63 · see citing works

Toll-Like Receptor 4 Deficiency Increases Disease and Mortality after Mouse Hepatitis Virus Type 1 Infection of Susceptible C3H Mice

Khanolkar, A., Hartwig, S. M., Haag, B. A., Meyerholz, D. K., Harty, J. T., & Varga, S. M. (2009) · Journal of Virology · doi:10.1128/jvi.01857-08 · Cited by 60 · see citing works

C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection.

Julander, J., Skirpstunas, R., Siddharthan, V., Shafer, K., Hoopes, J. D., Smee, D., & Morrey, J. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.01.007 · Cited by 58 · see citing works

The Interferon Inducer Ampligen [Poly(I)-Poly(C 12 U)] Markedly Protects Mice against Coxsackie B3 Virus-Induced Myocarditis

Padalko, E. Y., Nuyens, D., Palma, A. D., Verbeken, E. K., Aerts, J. L., Clercq, E. D., Carmeliet, P., & Neyts, J. H. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.267-274.2004 · Cited by 57 · see citing works

Autocrine Interferon Priming in Macrophages but Not Dendritic Cells Results in Enhanced Cytokine and Chemokine Production after Coronavirus Infection

Zhou, H., Zhao, J., & Perlman, S. M. (2010) · mBio · doi:10.1128/mbio.00219-10 · Cited by 45 · see citing works

Pathogenesis of acute and chronic central nervous system infection with variants of mouse hepatitis virus, strain JHM

Templeton, S. P., & Perlman, S. M. (2007) · Immunologic Research · doi:10.1007/s12026-007-0079-y · Cited by 42 · see citing works

Accessory Protein 5a Is a Major Antagonist of the Antiviral Action of Interferon against Murine Coronavirus

Koetzner, C. A., Kuo, L., Goebel, S. J., Dean, A. B., Parker, M. M., & Masters, P. S. (2010) · Journal of Virology · doi:10.1128/jvi.00385-10 · Cited by 40 · see citing works

Murine Coronavirus Cell Type Dependent Interaction with the Type I Interferon Response

Rose, K. M., & Weiss, S. R. (2009) · Viruses · doi:10.3390/v1030689 · Cited by 32 · see citing works

Macrophage interleukin‐6 and tumour necrosis factor‐α are induced by coronavirus fixation to Toll‐like receptor 2/heparan sulphate receptors but not carcinoembryonic cell adhesion antigen 1a

Jacques, A., Bleau, C., Turbide, C., Beauchemin, N., & Lamontagne, L. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02946.x · Cited by 32 · see citing works

TLR3 signaling is either protective or pathogenic for the development of Theiler's virus-induced demyelinating disease depending on the time of viral infection

Jin, Y.-H., Kaneyama, T., Kang, M. H., Kang, H. S., Koh, C., & Kim, B. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-178 · Cited by 29 · see citing works

Mismatched double-stranded RNA (polyI-polyC12U) is synergistic with multiple anti-HIV drugs and is active against drug-sensitive and drug-resistant HIV-1 in vitro

Essey, R. J., McDougall, B. R., & Robinson, W. E. (2001) · Antiviral Research · doi:10.1016/s0166-3542(01)00150-4 · Cited by 28 · see citing works

Murine Coronavirus Evolution In Vivo: Functional Compensation of a Detrimental Amino Acid Substitution in the Receptor Binding Domain of the Spike Glycoprotein

Navas, S., Hingley, S. T., & Weiss, S. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7629-7640.2005 · Cited by 25 · see citing works

Replicase Genes of Murine Coronavirus Strains A59 and JHM Are Interchangeable: Differences in Pathogenesis Map to the 3′ One-Third of the Genome

Navas, S., Brom, M., Chua, M. M., Watson, R., Qiu, Z., & Weiss, S. R. (2006) · Journal of Virology · doi:10.1128/jvi.01944-06 · Cited by 13 · see citing works

Mismatched dsRNA (Ampligen) induces protection against genomic variants of the human immunodeffciency virus type 1 (HIV-1) in a multiplicity of target cells

Montefiori, D. C., Robinson, W. E., & Mitchell, W. M. (1988) · Antiviral Research · doi:10.1016/0166-3542(88)90066-6 · Cited by 10 · see citing works

Activation and evasion of type I interferon responses by SARS-CoV-2

Lei, X., Dong, X., Ma, R., Wang, W., Xiao, X., Tian, Z., Wang, C., Wang, Y., Li, L., Ren, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17665-9 · Cited by 980 · see citing works

Toll-Like Receptors in Antiviral Innate Immunity

Lester, S. N., & Li, K. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.11.024 · Cited by 736 · see citing works

COVID-19 and the human innate immune system

Schultze, J. L., & Aschenbrenner, A. C. (2021) · Cell · doi:10.1016/j.cell.2021.02.029 · Cited by 714 · see citing works

FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units

FELASA working group on revision of guidelines for health monitoring of rodents and rabbits, Mähler (Convenor), M., Berard, M., Feinstein, R., Gallagher, A., Illgen-Wilcke, B., Pritchett-Corning, K., & Raspa, M. (2014) · Laboratory Animals · doi:10.1177/0023677213516312 · Cited by 646 · see citing works

The cGAS–STING pathway drives type I IFN immunopathology in COVID-19

Domizio, J. D., Gulen, M. F., Saidoune, F., Thacker, V. V., Yatim, A., Sharma, K., Nass, T., Guenova, E., Schaller, M., Conrad, C., et al. (2022) · Nature · doi:10.1038/s41586-022-04421-w · Cited by 538 · see citing works

Host Factors in Coronavirus Replication

de Wilde, A. H., Snijder, E. J., Kikkert, M., & van Hemert, M. J. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_25 · Cited by 542 · see citing works

Role of Toll‐like receptors in the pathogenesis of COVID‐19

Khanmohammadi, S., & Rezaei, N. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26826 · Cited by 371 · see citing works

Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines

Fara, A. F., Mitrev, Z. K., Rosalia, R. A., & Assas, M. B. (2020) · Open Biology · doi:10.1098/rsob.200160 · Cited by 368 · see citing works

TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection

Bortolotti, D., Gentili, V., Rizzo, S., Schiuma, G., Beltrami, S., Strazzabosco, G., Fernández, M., Caccuri, F., Caruso, A., & Rizzo, R. (2021) · Microorganisms · doi:10.3390/microorganisms9091820 · Cited by 190 · see citing works

Innate and adaptive immune responses against coronavirus

Hosseini, A., Hashemi, V., Shomali, N., Asghari, F., Gharibi, T., Akbari, M., Gholizadeh, S., & Jafari, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110859 · Cited by 162 · see citing works

Broad Cross-Species Infection of Cultured Cells by Bat HKU2-Related Swine Acute Diarrhea Syndrome Coronavirus and Identification of Its Replication in Murine Dendritic Cells In Vivo Highlight Its Potential for Diverse Interspecies Transmission

Yang, Y., Qin, P., Wang, B., Liu, Y., Xu, G.-H., Peng, L., Zhou, J., Zhu, S., & Huang, Y. (2019) · Journal of Virology · doi:10.1128/jvi.01448-19 · Cited by 137 · see citing works

Inhibition of Dengue and Chikungunya Virus Infections by RIG-I-Mediated Type I Interferon-Independent Stimulation of the Innate Antiviral Response

Olagnier, D. P., Scholte, F. E. M., Chiang, C., Albulescu, I. C., Nichols, C. N., He, Z., Lin, R., Snijder, E. J., van Hemert, M. J., & Hiscott, J. B. (2014) · Journal of Virology · doi:10.1128/jvi.03114-13 · Cited by 136 · see citing works

Toll‐like receptor 3 in viral pathogenesis: friend or foe?

Perales-Linares, R. F., & Navas, S. (2013) · Immunology · doi:10.1111/imm.12143 · Cited by 135 · see citing works

Systems Analysis of a RIG-I Agonist Inducing Broad Spectrum Inhibition of Virus Infectivity

Goulet, M.-L., Olagnier, D. P., Xu, Z.-Y., Paz, S., Belgnaoui, S. M., Lafferty, E. I., Janelle, V., Arguello, M., Paquet, M., Ghneim, K., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003298 · Cited by 118 · see citing works

Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity

Mengist, H. M., Kombe, A. J. K., Mekonnen, D. S., Abebaw, A., Getachew, M., & Jin, T. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101533 · Cited by 112 · see citing works

Novel Drugs Targeting Toll-Like Receptors for Antiviral Therapy

Patel, M. C., Shirey, K. A., Pletneva, L. M., Boukhvalova, M. S., Demo, A. G., Vogel, S. N., & Blanco, J. C. G. (2014) · Future Virology · doi:10.2217/fvl.14.70 · Cited by 102 · see citing works

Attenuation of Influenza A Virus Disease Severity by Viral Coinfection in a Mouse Model

Gonzalez, A. J., Ijezie, E. C., Balemba, O. B., & Miura, T. A. (2018) · Journal of Virology · doi:10.1128/jvi.00881-18 · Cited by 91 · see citing works

Brain Invasion by Mouse Hepatitis Virus Depends on Impairment of Tight Junctions and Beta Interferon Production in Brain Microvascular Endothelial Cells

Bleau, C., Filliol, A. A., Samson, M., & Lamontagne, L. (2015) · Journal of Virology · doi:10.1128/jvi.01501-15 · Cited by 86 · see citing works

Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice

Gralinski, L. E., Menachery, V. D., Morgan, A. P., Totura, A. L., Beall, A. E., Kocher, J., Plante, J. A., Harrison-Shostak, D. C., Schäfer, A., de Villena, F. P., et al. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.041434 · Cited by 76 · see citing works

Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model

Gu, T., Zhao, S., Jin, G., Song, M., Zhi, Y., Zhao, R., Ma, F., Zheng, Y., Wang, K., Liu, H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.621441 · Cited by 74 · see citing works

Innate Immune Sensing of Viruses and Its Consequences for the Central Nervous System

Singh, H., Koury, J., & Kaul, M. (2021) · Viruses · doi:10.3390/v13020170 · Cited by 72 · see citing works

SARS-CoV-2 Nsp5 Activates NF-κB Pathway by Upregulating SUMOylation of MAVS

Li, W., Qiao, J., You, Q., Zong, S., Peng, Q., Liu, Y., Hu, S., Liu, W., Li, S., Shu, X., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750969 · Cited by 70 · see citing works

Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy

Boroujeni, M. E., Sekrecka, A., Antonczyk, A., Hassani, S., Sekrecki, M., Nowicka, H., Łopacinska, N., Olya, A., Kluzek, K., Wesoły, J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888897 · Cited by 71 · see citing works

Toll‐like receptors in health and disease

Wang, K., Huang, H., Qi, Z., Ding, H., & Li, Y. (2024) · MedComm · doi:10.1002/mco2.549 · Cited by 68 · see citing works

Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses

Hwang, M., & Bergmann, C. C. (2018) · Journal of Virology · doi:10.1128/jvi.01901-17 · Cited by 63 · see citing works

Design an Efficient Multi-Epitope Peptide Vaccine Candidate Against SARS-CoV-2: An in silico Analysis

Yazdani, Z., Rafiei, A., Yazdani, M., & Valadan, R. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s264573 · Cited by 64 · see citing works

Immune evasion of SARS-CoV-2 from interferon antiviral system

Min, Y., Huang, M., Sun, X., Dèng, F., Wáng, H., & Ning, Y. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.023 · Cited by 61 · see citing works

A molecular arms race between host innate antiviral response and emerging human coronaviruses

Wong, L.-Y. R., Lui, P., & Jin, D. (2016) · Virologica Sinica · doi:10.1007/s12250-015-3683-3 · Cited by 59 · see citing works

Targeting Toll-Like Receptors in Sepsis: From Bench to Clinical Trials

Chen, F., Zou, L., Williams, B., & Chao, W. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0005 · Cited by 61 · see citing works

Analysis of protein expression changes of the Vero E6 cells infected with classic PEDV strain CV777 by using quantitative proteomic technique

Sun, D., Shi, H., Guo, D., Chen, J., Shi, D., Zhu, Q., Zhang, X., & Feng, L. (2015) · Journal of Virological Methods · doi:10.1016/j.jviromet.2015.03.002 · Cited by 49 · see citing works

Responses of the Toll-like receptor and melanoma differentiation-associated protein 5 signaling pathways to avian infectious bronchitis virus infection in chicks

He, Y., Xie, Z., Dai, J., Yanjie, C., Hou, J., Zheng, Y., Wei, T., Mo, M., & Wei, P. (2016) · Virologica Sinica · doi:10.1007/s12250-015-3696-y · Cited by 49 · see citing works

Coagulation Disorders in COVID-19: Role of Toll-like Receptors

Biswas, I., & Khan, G. A. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s271768 · Cited by 44 · see citing works

Host Defence RNases as Antiviral Agents against Enveloped Single Stranded RNA Viruses

Li, J. R., & Boix, E. (2021) · Virulence · doi:10.1080/21505594.2021.1871823 · Cited by 42 · see citing works

Multiepitope Subunit Vaccine Design against COVID‐19 Based on the Spike Protein of SARS‐CoV‐2: An In Silico Analysis

Dar, H. A., Waheed, Y., Najmi, M. H., Ismail, S., Hetta, ‏. F., Ali, A., & Muhammad, K. (2020) · Journal of Immunology Research · doi:10.1155/2020/8893483 · Cited by 42 · see citing works

Polychlorinated Biphenyls (PCB 101, 153, and 180) Impair Murine Macrophage Responsiveness to Lipopolysaccharide: Involvement of NF-κB Pathway

Santoro, A. N., Ferrante, M. C., Guida, F., Pirozzi, C., Lama, A., Simeoli, R., Clausi, M. T., Monnolo, A., Mollica, M. P., Raso, G. M., et al. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv127 · Cited by 37 · see citing works

Inflammatory Mediators in the Mesenteric Lymph Nodes, Site of a Possible Intermediate Phase in the Immune Response to Feline Coronavirus and the Pathogenesis of Feline Infectious Peritonitis?

Malbon, A. J., Meli, M. L., Barker, E., Davidson, A. D., Tasker, S., & Kipar, A. (2018) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2018.11.001 · Cited by 35 · see citing works

Advances in Antiviral Therapies Targeting Toll-like Receptors

Shah, M., Anwar, M. A., Kim, J., & Choi, S. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1154040 · Cited by 33 · see citing works

Immune response against epidemic coronaviruses

Pashenkov, M. V., & Khaitov, R. M. (2020) · Immunologiya · doi:10.33029/0206-4952-2020-41-1-5-18 · Cited by 37 · see citing works

Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences

Shiraki, K., Sato, N., Sakai, K., Matsumoto, S., Kaszynski, R. H., & Takemoto, M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108121 · Cited by 33 · see citing works

Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication

Vanderwall, E. R., Barrow, K. A., Rich, L. M., Read, D. F., Trapnell, C., Okoloko, O., Ziegler, S. F., Hallstrand, T. S., White, M. P., & Debley, J. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-10763-2 · Cited by 31 · see citing works

Regulation of cGAS Activity and Downstream Signaling

Joshi, B., Joshi, J. C., & Mehta, D. (2022) · Cells · doi:10.3390/cells11182812 · Cited by 32 · see citing works

Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells

Gunnarsdottir, F. B., Briem, O., Lindgren, A. Y., Källberg, E., Andersen, C., Grenthe, R., Rosenqvist, C., Millrud, C. R., Wallgren, M., Viklund, H., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1180209 · Cited by 28 · see citing works

Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review

Kozłowski, P., Leszczyńska, A., & Ciepiela, O. (2024) · American Journal of Medicine Open · doi:10.1016/j.ajmo.2024.100068 · Cited by 27 · see citing works

Correction: Systems Analysis of a RIG-I Agonist Inducing Broad Spectrum Inhibition of Virus Infectivity

Goulet, M.-L., Olagnier, D. P., Xu, Z.-Y., Paz, S., Belgnaoui, S. M., Lafferty, E. I., Janelle, V., Arguello, M., Paquet, M., He, Z., et al. (2013) · PLoS Pathogens · doi:10.1371/annotation/8fa70b21-32e7-4ed3-b397-ab776b5bbf30 · Cited by 26 · see citing works

Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach

Manan, A., Pirzada, R. H., Haseeb, M., & Choi, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810716 · Cited by 21 · see citing works

An Overview of Current Knowledge of Deadly CoVs and Their Interface with Innate Immunity

Zhang, Y., Gargan, S., Lu, Y., & Stevenson, N. J. (2021) · Viruses · doi:10.3390/v13040560 · Cited by 18 · see citing works

Infectious bronchitis virus inhibits activation of the TLR7 pathway, but not the TLR3 pathway

Zhu, J., Xu, S., Li, X., Wang, J., Jiang, Y., Hu, W., & Ruan, W. (2020) · Archives of Virology · doi:10.1007/s00705-020-04690-8 · Cited by 18 · see citing works

An update on host immunity correlates and prospects of re-infection in COVID-19

Negi, N., Maurya, S. P., Singh, R., & Das, B. K. (2021) · International Reviews of Immunology · doi:10.1080/08830185.2021.2019727 · Cited by 18 · see citing works

Feline Coronavirus and Alpha-Herpesvirus Infections: Innate Immune Response and Immune Escape Mechanisms

Capozza, P., Pratelli, A., Camero, M., Lanave, G., Greco, G., Pellegrini, F., & Tempesta, M. (2021) · Animals · doi:10.3390/ani11123548 · Cited by 17 · see citing works

Identification of serum metabolites enhancing inflammatory responses in COVID-19

Zhang, C., Zhang, B., Li, M., Wei, X., Gong, K., Li, Z., Yao, X., Wu, J., Zhang, C., Zhu, M., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2099-7 · Cited by 17 · see citing works

SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells

Savellini, G. G., Anichini, G., & Cusi, M. G. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199134 · Cited by 17 · see citing works

Toll‐like receptor‐2 exacerbates murine acute viral hepatitis

Bleau, C., Burnette, M., Filliol, A. A., Piquet‐Pellorce, C., Samson, M., & Lamontagne, L. (2016) · Immunology · doi:10.1111/imm.12627 · Cited by 17 · see citing works

Engineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins

Rajput, V. S., Sharma, R., Kumari, A., Vyas, N., Prajapati, V. K., & Grover, A. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1924265 · Cited by 15 · see citing works

SARS-CoV-2 S protein disrupts the formation of ISGF3 complex through conserved S2 subunit to antagonize type I interferon response

Ni, W., Li, W., Cai, Z., Guo, W., Zheng, Y., Zhao, Y., Wu, Z., Liang, S., Ye, J., Guo, X., et al. (2024) · Journal of Virology · doi:10.1128/jvi.01516-24 · Cited by 16 · see citing works

Vitamin D3 Attenuates Viral-Induced Inflammation and Fibrotic Responses in Bronchial Smooth Muscle Cells

Plesa, M., Gaudet, M., Mogas, A. K., Jalaleddine, N., Halayko, A. J., Heialy, S. A., & Hamid, Q. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.715848 · Cited by 15 · see citing works

Infection, inflammation and thrombosis: a review of potential mechanisms mediating arterial thrombosis associated with influenza and severe acute respiratory syndrome coronavirus 2

Veizades, S. A., Tso, A., & Nguyen, P. K. P. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0348 · Cited by 12 · see citing works

Endogenous IL-33 Deficiency Exacerbates Liver Injury and Increases Hepatic Influx of Neutrophils in Acute Murine Viral Hepatitis

Carrière, V., Arshad, M. I., Seyec, J. L., Lefèvre, B., Farooq, M., Jan, A., Manuel, C., Touami-Bernard, L., Lucas‐Clerc, C., Genêt, V., et al. (2017) · Mediators of Inflammation · doi:10.1155/2017/1359064 · Cited by 12 · see citing works

The chemokine receptor CXCR2 and coronavirus-induced neurologic disease

Weinger, J. G., Marro, B. S., Hosking, M., & Lane, T. E. (2012) · Virology · doi:10.1016/j.virol.2012.08.049 · Cited by 11 · see citing works

Canine Coronavirus Infection Modulates the Biogenesis and Composition of Cell-Derived Extracellular Vesicles

Pandit, R., Ipinmoroti, A. O., Crenshaw, B. J., Li, T., & Matthews, Q. L. (2023) · Biomedicines · doi:10.3390/biomedicines11030976 · Cited by 10 · see citing works

Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein

Nangarlia, A., Hassen, F. F., Canziani, G., Bandi, P., Talukder, C., Zhang, F., Krauth, D., Gary, E. N., Weiner, D. B., Bieniasz, P. D., et al. (2023) · Biochemistry · doi:10.1021/acs.biochem.3c00109 · Cited by 10 · see citing works

[Role of toll-like receptors (TLRs) and nucleotide-binding oligomerization domain receptors (NLRs) in viral infections].

Durán, A., Álvarez‐Mon, M., & Valero, N. J. (2014) · PubMed · Cited by 9 · see citing works

Surfactant-Impregnated MOF-Coated Fabric for Antimicrobial Applications

Schwenk, G. R., Glass, A. M., Ji, H., Ehrlich, G. D., Navas, S., Król, J. E., & Hall, D. C. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00860 · Cited by 8 · see citing works

The impact of Hyssop (Hyssopus officinalis) extract on activation of endosomal toll like receptors and their downstream signaling pathways

Ghasempour, M., Hosseini, M., Soltani‐Zangbar, M. S., Motavalli, R., Maleki, L. A., Dolati, S., Mehdizadeh, A., Yousefi, M., & Heris, J. A. (2022) · BMC Research Notes · doi:10.1186/s13104-022-06253-3 · Cited by 7 · see citing works

Shedding Lights on the Extracellular Vesicles as Functional Mediator and Therapeutic Decoy for COVID-19

Thakur, A. (2023) · Life · doi:10.3390/life13030840 · Cited by 7 · see citing works

Curcumin attenuates poly(I:C)-induced immune and inflammatory responses in mouse macrophages by inhibiting TLR3/TBK1/IFNB cascade

Zhang, X., Chen, L., Hu, C., Fast, D. J., Zhang, L., Yang, B., Kan, J., & Du, J. C. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.104949 · Cited by 7 · see citing works

Small Interfering RNA Expression Inhibits Avian Infectious Bronchitis virus Replication and Inflammatory Response

Yu, K., Deng, S., Wang, H., Zhang, Y., Chen, X., Wang, K., Hu, R. X., Lian, Z., & Li, N. (2015) · Antiviral Therapy · doi:10.3851/imp3027 · Cited by 5 · see citing works

Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV

Akbarpour, M., Sharifi, L., Safdarian, A. R., Farhangnia, P., Borjkhani, M., & Rezaei, N. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-63761-3_9 · Cited by 5 · see citing works

Molecular mechanism of SARS-CoV-2 components caused ARDS in murine modelPreprint

Gu, T., Zhao, S., Jin, G., Song, M., Zhi, Y., Zhao, R., Ma, F., Zheng, Y., Wang, K., Liu, H., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.07.119032 · Cited by 5 · see citing works

Chinese Medicine for Treatment of COVID-19: A Review of Potential Pharmacological Components and Mechanisms

Xu, Q., Yu, D., Fan, X., Cui, H., Dai, Q., Zhong, X.-Y., Zhang, X., Zhao, C., You, L., & Shang, H. (2024) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-024-3909-z · Cited by 4 · see citing works

VAX014 Activates Tumor-Intrinsic STING and RIG-I to Promote the Development of Antitumor Immunity

Nelson, K. L., Reil, K. A., Tsuji, S., Parikh, A. M., Robinson, M., House, C. D., McGuire, K. L., & Giacalone, M. J. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-0509 · Cited by 3 · see citing works

How the immune response to the structural proteins of SARS-CoV-2 affects the retinal vascular endothelial cells: an immune thrombotic and/or endotheliopathy process with in silico modeling

Kutlutürk, I., Tokuc, E. O., Karabas, L., Rückert, R., Kaya, M., Karagöz, A., & Munk, M. R. (2023) · Immunologic research · doi:10.1007/s12026-023-09412-1 · Cited by 2 · see citing works

Immunoediting in SARS-CoV-2: Mutual relationship between the virus and the host

Kheshtchin, N., Bakhshi, P., Arab, S., & Nourizadeh, M. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108531 · Cited by 2 · see citing works

Understanding Feline Infectious Peritonitis: Serotypes, Patho-genicity, and Diagnostic ChallengesPreprint

Li, S., Cui, Y., Zhou, J., Hou, L., Feng, X., & Liu, J. (2023) · Preprints.org · doi:10.20944/preprints202305.0519.v1 · Cited by 2 · see citing works

Human Challenge Studies with Coronaviruses Old and New

McKendry, R., Lemm, N., Papargyris, L., & Chiu, C. (2021) · Current topics in microbiology and immunology · doi:10.1007/82_2021_247 · Cited by 1 · see citing works

Effect of Ligands to Toll-Like Receptors (TLR) 3, 7 and 9 on Mice Infected with Mouse Hepatitis Virus A59

Aparicio, J. L., Vega, M. D., & Retegui, L. A. (2014) · Open Journal of Immunology · doi:10.4236/oji.2014.44015 · Cited by 1 · see citing works

Progress in using the drugs based on hydrobionts in treatment of respiratory viral infections and their complications

Katelnikova, A. E., Макаров, В. Г., Vorobieva, V. V., Pozharitskaya, O. N., Shikov, A. N., & Shabanov, P. D. (2017) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf1514-13 · Cited by 1 · see citing works

Targeting TLR-4 Signaling to Treat COVID-19-induced Acute Kidney Injury

Almazmomi, M. A., & Alsieni, M. (2022) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.1177/0976500x221147798 · Cited by 1 · see citing works

A review on SARS-CoV2 drug regimens inferring plausible mechanisms to impede the viral propagation and cytokine storm

Chatterjee, P., Mishra, N. P., Das, A., & Acharya, S. (2021) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20211281 · Cited by 1 · see citing works

Analysis of the mechanism of spongiform degeneration induced by neuropathogenic mouse hepatitis virus

Kashiwazaki, H. (2014)

Coronaviruses of wild and semidomesticated animals with the potential for zoonotic transmission

Beltz, L. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98809-4.00010-3

Innate immune responses in COVID-19

Jacotot, E. D., Talamini, L., Bonam, S. R., Vieira, A. T., Frémeaux‐Bacchi, V., Radic, M. Z., Dragon‐Durey, M., Lozano, J. M., Saia, R. S., & Muller, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00041-4

Development of plant-produced subunit vaccine and therapeutic protein for COVID-19

Siriwattananon, K. (2021) · doi:10.58837/chula.the.2021.306

Lipopolysaccharide Enhances Microglia Antiviral Control of Betacoronavirus Infection through TLR4-Dependent Induction of IFNβ with Concomitant Modulation of dsRNA Sensors MDA5 and TLR3Preprint

Davis, E., Glass, A. M., LaBier, B. A., Tang, A., Pabon, V. B., Mayes, A. A., & Navas, S. (2024) · Research Square · doi:10.21203/rs.3.rs-4438872/v1

The role of innate immune cells in the pathogenesis of coronavirus infection caused by SARS-CoV-2

Mikhailov, A. O., Плехова, Н. Г., Toropkova, L. A., Анатольевна, С. С., & Belevich, I. O. (2025) · Acta medica Eurasica · doi:10.47026/2413-4864-2025-3-68-97

Additional file 3 of The impact of Hyssop (Hyssopus officinalis) extract on activation of endosomal toll like receptors and their downstream signaling pathways

Ghasempour, M., Hosseini, M., Soltani‐Zangbar, M. S., Motavalli, R., Maleki, L. A., Dolati, S., Mehdizadeh, A., Yousefi, M., & Heris, J. A. (2024) · Figshare · doi:10.6084/m9.figshare.26553158

Additional file 1 of The impact of Hyssop (Hyssopus officinalis) extract on activation of endosomal toll like receptors and their downstream signaling pathways

Ghasempour, M., Hosseini, M., Soltani‐Zangbar, M. S., Motavalli, R., Maleki, L. A., Dolati, S., Mehdizadeh, A., Yousefi, M., & Heris, J. A. (2024) · Figshare · doi:10.6084/m9.figshare.26553152

Additional file 2 of The impact of Hyssop (Hyssopus officinalis) extract on activation of endosomal toll like receptors and their downstream signaling pathways

Ghasempour, M., Hosseini, M., Soltani‐Zangbar, M. S., Motavalli, R., Maleki, L. A., Dolati, S., Mehdizadeh, A., Yousefi, M., & Heris, J. A. (2024) · Figshare · doi:10.6084/m9.figshare.26553155

Immunological Persistence and Risk of SARS-CoV-2 Reinfection: Insights and Implications

Kumar, S., & BASU, M. N. (2025) · Medical virology · doi:10.1007/978-981-95-1426-7_11

Inhibition du Virus de l’Hépatite Delta par des inducteurs de la voie NFκB

Chardès, B. (2019) · doi:10.70675/1f17682fza956z4ba1za8c0za470231e90d4

Article Protective Role of Toll-like Receptor 3-Induced Type I Interferon in Murine Coronavirus Infection of Macrophages

Mazaleuskaya, L. L., Veltrop, R. J. A., Ikpeze, N., & Martín‐García, J. (2012)

Contrasting effects of triggering Toll-Like Receptors 2, 3, 4, and 7 in the macrophage susceptibility to murine coronavirus infections

Mazaleuskaya, L. L., & Navas, S. (2012) · doi:10.17918/00009740

Reprogramming of Murine Macrophages through TLR2 Confers Viral Resistance via TRAF3-Mediated, Enhanced Interferon Production

Perkins, D. J., Polumuri, S. K., Pennini, M. E., Lai, W., Xie, P., & Vogel, S. N. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003479 · Cited by 47 · see citing works

The antiviral role of Toll-like receptor 3 in macrophages infected with respiratory syncytial virus.

XiaoYi, S., & ShengHai, H. (2010) · Zhongguo renshougonghuanbing zazhi

Murine Coronavirus Mouse Hepatitis Virus Is Recognized by MDA5 and Induces Type I Interferon in Brain Macrophages/Microglia

Roth-Cross, J. K., Bender, S. J., & Weiss, S. R. (2008) · Journal of Virology · doi:10.1128/jvi.01199-08 · Cited by 228 · see citing works